Versant Venture Management as of Sept. 30, 2025
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 9 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Lenz Therapeutics Common Stock (LENZ) | 58.3 | $124M | 2.7M | 46.58 | |
| Monte Rosa Therapeutics Common Stock (GLUE) | 19.7 | $42M | 5.7M | 7.41 | |
| Jade Biosciences Common Stock (JBIO) | 6.2 | $13M | 1.5M | 8.63 | |
| CRISPR Therapeutics Common Shares (CRSP) | 4.5 | $9.6M | 149k | 64.81 | |
| Skye Bioscience Common Stock (SKYE) | 3.7 | $7.9M | 2.0M | 3.93 | |
| Contineum Therapeutics Common Stock (CTNM) | 3.0 | $6.4M | 543k | 11.75 | |
| Repare Therapeutics Common Stock (RPTX) | 2.2 | $4.7M | 2.6M | 1.76 | |
| Tempest Therapeutics Common Stock | 1.3 | $2.8M | 270k | 10.28 | |
| Adverum Biotechnologies Common Stock | 1.1 | $2.3M | 507k | 4.53 |
